|
2025-04-04 |
2025-04-03 |
A
Achat
|
Thompson Peter A.
Administrateur non-exécutif
Actionnaire important
|
124 193
+38.9%
20,13
2 500 005 USD
|
124 193
+38.9%
|
20,13
|
2 500 005 USD
|
|
|
2025-04-04 |
2025-04-03 |
A
Achat
|
Thompson Peter A.
Administrateur non-exécutif
Actionnaire important
|
372 578
+2.6%
20,13
7 499 995 USD
|
372 578
+2.6%
|
20,13
|
7 499 995 USD
|
|
|
2025-04-04 |
2025-04-03 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Actionnaire important
|
124 193
+38.9%
20,13
2 500 005 USD
|
124 193
+38.9%
|
20,13
|
2 500 005 USD
|
|
|
2025-04-04 |
2025-04-03 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Actionnaire important
|
372 578
+2.6%
20,13
7 499 995 USD
|
372 578
+2.6%
|
20,13
|
7 499 995 USD
|
|
|
2025-03-11 |
2025-03-07 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
200
-1.3%
30,02
6 004 USD
|
200
-1.3%
|
30,02
|
6 004 USD
|
|
|
2025-03-11 |
2025-03-07 |
VP
Vente planifiée
|
KOCH KEVIN
President and CEO
Administrateur exécutif
|
100
-0.7%
30,00
3 000 USD
|
100
-0.7%
|
30,00
|
3 000 USD
|
|
|
2025-02-07 |
2025-02-06 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
1 200
-7.5%
30,13
36 153 USD
|
1 200
-7.5%
|
30,13
|
36 153 USD
|
|
|
2025-02-07 |
2025-02-06 |
VP
Vente planifiée
|
KOCH KEVIN
President and CEO
Administrateur exécutif
|
900
-5.9%
31,13
28 018 USD
|
900
-5.9%
|
31,13
|
28 018 USD
|
|
|
2025-02-07 |
2025-02-05 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
8 015
-35.0%
30,02
240 623 USD
|
8 015
-35.0%
|
30,02
|
240 623 USD
|
|
|
2025-02-07 |
2025-02-05 |
VP
Vente planifiée
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
10 000
-37.3%
30,03
300 300 USD
|
10 000
-37.3%
|
30,03
|
300 300 USD
|
|
|
2025-02-07 |
2025-02-05 |
VP
Vente planifiée
|
KOCH KEVIN
President and CEO
Administrateur exécutif
|
8 636
-37.4%
30,03
259 298 USD
|
8 636
-37.4%
|
30,03
|
259 298 USD
|
|
|
2025-01-30 |
2025-01-28 |
V
Vente
|
Donovan Joanne M.
CMO
Dirigeant
|
25 000
-60.4%
27,63
690 658 USD
|
25 000
-60.4%
|
27,63
|
690 658 USD
|
|
|
2024-12-31 |
2024-12-30 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
100 000
-87.1%
27,37
2 737 470 USD
|
100 000
-87.1%
|
27,37
|
2 737 470 USD
|
|
|
2024-12-27 |
2024-12-24 |
V
Vente
|
Semigran Marc
Chief Development Officer
Dirigeant
|
1 729
-20.5%
30,08
52 009 USD
|
1 729
-20.5%
|
30,08
|
52 009 USD
|
|
|
2024-12-27 |
2024-12-24 |
VP
Vente planifiée
|
Semigran Marc
Chief Development Officer
Dirigeant
|
27 980
-76.8%
29,66
829 906 USD
|
27 980
-76.8%
|
29,66
|
829 906 USD
|
|
|
2024-09-24 |
2024-09-23 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
20 922
-86.5%
27,63
578 064 USD
|
20 922
-86.5%
|
27,63
|
578 064 USD
|
|
|
2024-09-24 |
2024-09-20 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
42 068
-73.6%
29,03
1 221 133 USD
|
42 068
-73.6%
|
29,03
|
1 221 133 USD
|
|
|
2024-09-24 |
2024-09-20 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
815
-6.0%
29,51
24 049 USD
|
815
-6.0%
|
29,51
|
24 049 USD
|
|
|
2024-09-24 |
2024-09-20 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
74 185
-84.6%
28,25
2 096 053 USD
|
74 185
-84.6%
|
28,25
|
2 096 053 USD
|
|
|
2024-09-24 |
2024-09-20 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
50 000
-93.9%
28,37
1 418 510 USD
|
50 000
-93.9%
|
28,37
|
1 418 510 USD
|
|
|
2024-09-24 |
2024-09-20 |
VP
Vente planifiée
|
Donovan Joanne M.
CMO
Dirigeant
|
7 162
-33.0%
28,29
202 603 USD
|
7 162
-33.0%
|
28,29
|
202 603 USD
|
|
|
2024-09-24 |
2024-09-20 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
50 000
-87.9%
28,55
1 427 385 USD
|
50 000
-87.9%
|
28,55
|
1 427 385 USD
|
|
|
2024-09-24 |
2024-09-20 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
24 960
-78.3%
28,59
713 512 USD
|
24 960
-78.3%
|
28,59
|
713 512 USD
|
|
|
2024-09-24 |
2024-09-20 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
4 064
-11.3%
28,59
116 174 USD
|
4 064
-11.3%
|
28,59
|
116 174 USD
|
|
|
2024-09-24 |
2024-09-20 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
46 068
-56.2%
28,59
1 316 909 USD
|
46 068
-56.2%
|
28,59
|
1 316 909 USD
|
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
2 157
-5.8%
18,91
40 789 USD
|
2 157
-5.8%
|
18,91
|
40 789 USD
|
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
Donovan Joanne M.
CMO
Dirigeant
|
3 682
-15.6%
18,91
69 627 USD
|
3 682
-15.6%
|
18,91
|
69 627 USD
|
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
1 956
-37.6%
18,91
36 988 USD
|
1 956
-37.6%
|
18,91
|
36 988 USD
|
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
1 576
-17.9%
18,91
29 802 USD
|
1 576
-17.9%
|
18,91
|
29 802 USD
|
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
KOCH KEVIN
President and CEO
Administrateur exécutif
|
3 152
-17.9%
18,91
59 604 USD
|
3 152
-17.9%
|
18,91
|
59 604 USD
|
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
1 718
-11.3%
18,91
32 487 USD
|
1 718
-11.3%
|
18,91
|
32 487 USD
|
|
|
2024-02-09 |
2024-02-09 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
4 800
-40.6%
20,04
96 209 USD
|
4 800
-40.6%
|
20,04
|
96 209 USD
|
|
|
2024-02-09 |
2024-02-09 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
8 029
-100.0%
20,01
160 657 USD
|
8 029
-100.0%
|
20,01
|
160 657 USD
|
|
|
2024-02-09 |
2024-02-08 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
4 600
-39.6%
20,01
92 049 USD
|
4 600
-39.6%
|
20,01
|
92 049 USD
|
|
|
2024-02-09 |
2024-02-08 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
3 813
-100.0%
20,01
76 285 USD
|
3 813
-100.0%
|
20,01
|
76 285 USD
|
|
|
2024-02-09 |
2024-02-07 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
600
-7.9%
20,00
12 000 USD
|
600
-7.9%
|
20,00
|
12 000 USD
|
|
|
2024-02-09 |
2024-02-07 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
17 993
-100.0%
20,00
359 864 USD
|
17 993
-100.0%
|
20,00
|
359 864 USD
|
|
|
2024-01-25 |
2024-01-23 |
A
Achat
|
Thompson Peter A.
Administrateur non-exécutif
Actionnaire important
|
454 545
+3.3%
11,00
4 999 995 USD
|
454 545
+3.3%
|
11,00
|
4 999 995 USD
|
|
|
2024-01-25 |
2024-01-23 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Actionnaire important
|
454 545
+3.3%
11,00
4 999 995 USD
|
454 545
+3.3%
|
11,00
|
4 999 995 USD
|
|
|
2024-01-25 |
2024-01-23 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
90 000
-75.6%
15,78
1 419 759 USD
|
90 000
-75.6%
|
15,78
|
1 419 759 USD
|
|
|
2023-12-28 |
2023-12-27 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
8 497
-100.0%
10,50
89 219 USD
|
8 497
-100.0%
|
10,50
|
89 219 USD
|
|
|
2023-12-28 |
2023-12-26 |
A
Achat
|
Fox Jonathan C
Administrateur non-exécutif
|
10 857
+inf%
9,30
100 958 USD
|
10 857
+inf%
|
9,30
|
100 958 USD
|
|
|
2023-12-28 |
2023-12-26 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
172 585
-98.0%
9,33
1 610 097 USD
|
172 585
-98.0%
|
9,33
|
1 610 097 USD
|
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Donovan Joanne M.
CMO
Dirigeant
|
3 254
-24.6%
8,90
28 977 USD
|
3 254
-24.6%
|
8,90
|
28 977 USD
|
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
1 897
-22.4%
8,90
16 893 USD
|
1 897
-22.4%
|
8,90
|
16 893 USD
|
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
1 602
-0.9%
8,90
14 266 USD
|
1 602
-0.9%
|
8,90
|
14 266 USD
|
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
1 336
-7.7%
8,90
11 897 USD
|
1 336
-7.7%
|
8,90
|
11 897 USD
|
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
1 747
-19.9%
8,90
15 557 USD
|
1 747
-19.9%
|
8,90
|
15 557 USD
|
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
KOCH KEVIN
President and CEO
Administrateur exécutif
|
3 203
-30.8%
8,90
28 522 USD
|
3 203
-30.8%
|
8,90
|
28 522 USD
|
|
|
2022-10-05 |
2022-10-03 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
4 730
-61.2%
9,76
46 155 USD
|
4 730
-61.2%
|
9,76
|
46 155 USD
|
|
|
2022-09-16 |
2022-09-16 |
A
Achat
|
Thompson Peter A.
Administrateur non-exécutif
Actionnaire important
|
484 496
+3.6%
10,32
4 999 999 USD
|
484 496
+3.6%
|
10,32
|
4 999 999 USD
|
|
|
2022-09-16 |
2022-09-16 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Actionnaire important
|
484 496
+3.6%
10,32
4 999 999 USD
|
484 496
+3.6%
|
10,32
|
4 999 999 USD
|
|
|
2022-09-16 |
2022-09-14 |
A
Achat
|
Novo Holdings A/S
Actionnaire important
|
484 496
+8.7%
10,32
4 999 999 USD
|
484 496
+8.7%
|
10,32
|
4 999 999 USD
|
|
|
2022-09-08 |
2022-09-06 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
2 351
-43.9%
10,99
25 842 USD
|
2 351
-43.9%
|
10,99
|
25 842 USD
|
|
|
2022-09-08 |
2022-09-06 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
2 379
-30.8%
10,83
25 756 USD
|
2 379
-30.8%
|
10,83
|
25 756 USD
|
|
|
2022-08-05 |
2022-08-03 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
9 232
-75.5%
9,31
85 921 USD
|
9 232
-75.5%
|
9,31
|
85 921 USD
|
|
|
2022-07-07 |
2022-07-06 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
1 046
-25.9%
8,54
8 928 USD
|
1 046
-25.9%
|
8,54
|
8 928 USD
|
|
|
2022-07-07 |
2022-07-05 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
8 186
-73.2%
8,35
68 329 USD
|
8 186
-73.2%
|
8,35
|
68 329 USD
|
|
|
2022-06-21 |
2022-06-21 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
31 078
-91.2%
7,29
226 695 USD
|
31 078
-91.2%
|
7,29
|
226 695 USD
|
|
|
2022-06-21 |
2022-06-17 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
22 127
-88.1%
6,62
146 434 USD
|
22 127
-88.1%
|
6,62
|
146 434 USD
|
|
|
2022-06-21 |
2022-06-16 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
14 722
-83.1%
6,17
90 805 USD
|
14 722
-83.1%
|
6,17
|
90 805 USD
|
|
|
2022-06-15 |
2022-06-15 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
18 075
-85.8%
6,11
110 445 USD
|
18 075
-85.8%
|
6,11
|
110 445 USD
|
|
|
2022-06-15 |
2022-06-15 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
585
-2.7%
6,11
3 575 USD
|
585
-2.7%
|
6,11
|
3 575 USD
|
|
|
2022-06-15 |
2022-06-14 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
3 628
-54.7%
6,02
21 855 USD
|
3 628
-54.7%
|
6,02
|
21 855 USD
|
|
|
2022-06-15 |
2022-06-13 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
4 093
-57.7%
6,01
24 582 USD
|
4 093
-57.7%
|
6,01
|
24 582 USD
|
|
|
2022-06-10 |
2022-06-10 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
7 125
-70.4%
6,05
43 120 USD
|
7 125
-70.4%
|
6,05
|
43 120 USD
|
|
|
2022-06-10 |
2022-06-09 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
7 615
-71.7%
6,49
49 397 USD
|
7 615
-71.7%
|
6,49
|
49 397 USD
|
|
|
2022-06-10 |
2022-06-08 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
12 566
-80.7%
6,63
83 362 USD
|
12 566
-80.7%
|
6,63
|
83 362 USD
|
|
|
2022-06-07 |
2022-06-07 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
17 150
-85.1%
6,61
113 276 USD
|
17 150
-85.1%
|
6,61
|
113 276 USD
|
|
|
2022-06-07 |
2022-06-07 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
973
-24.5%
6,61
6 427 USD
|
973
-24.5%
|
6,61
|
6 427 USD
|
|
|
2022-06-07 |
2022-06-06 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
13 934
-82.3%
6,03
84 085 USD
|
13 934
-82.3%
|
6,03
|
84 085 USD
|
|
|
2022-06-07 |
2022-06-03 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
15 230
-83.5%
6,05
92 198 USD
|
15 230
-83.5%
|
6,05
|
92 198 USD
|
|
|
2022-05-20 |
2022-05-18 |
A
Achat
|
Thompson Peter A.
Administrateur non-exécutif
Actionnaire important
|
138 000
+1.0%
7,21
994 980 USD
|
138 000
+1.0%
|
7,21
|
994 980 USD
|
|
|
2022-05-20 |
2022-05-18 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Actionnaire important
|
138 000
+1.0%
7,21
994 980 USD
|
138 000
+1.0%
|
7,21
|
994 980 USD
|
|
|
2022-05-18 |
2022-05-16 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
10 800
-78.3%
7,42
80 146 USD
|
10 800
-78.3%
|
7,42
|
80 146 USD
|
|
